Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
Abstract Immunotherapy, specifically immune checkpoint inhibitors, is revolutionizing cancer treatment, achieving durable control of previously incurable or advanced tumors. However, only a certain group of patients exhibit effective responses to immunotherapy. Anti‐angiogenic therapy aims to block...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley-VCH
2024-01-01
|
| Ráidu: | Interdisciplinary Medicine |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/INMD.20230025 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|